Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             61 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study MIKI, M.
2006
10 p. 1445-1451
artikel
2 An open-label study of rabeprazole in patients with Zollinger–Ellison syndrome or idiopathic gastric acid hypersecretion MOROCUTTI, A.
2006
10 p. 1439-1444
artikel
3 A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis VAN DEVENTER, S. J. H.
2006
10 p. 1415-1425
artikel
4 Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease CREED, T. J.
2006
10 p. 1435-1442
artikel
5 Bilirubin and colorectal cancer V itek, L.
2006
10 p. 1503-1504
artikel
6 Bilirubin and colorectal cancer: authors' reply I oannou, G. N.
2006
10 p. 1504
artikel
7 Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis MINER, P. B.
2006
10 p. 1427-1434
artikel
8 Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? LEVI, Z.
2006
10 p. 1475-1481
artikel
9 Clinical, subclinical and potential autoimmune diseases in an Italian population of children with coeliac disease GUARISO, G.
2007
10 p. 1409-1417
artikel
10 Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn DICKMAN, R.
2007
10 p. 1333-1344
artikel
11 Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B LIM, S. G.
2007
10 p. 1419-1428
artikel
12 Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia THUMSHIRN, M.
2007
10 p. 1399-1407
artikel
13 Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors – a follow-up study of intraluminal-impedance guided therapy BECKER, V.
2007
10 p. 1355-1360
artikel
14 Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation LICHTENSTEIN, G. R.
2007
10 p. 1361-1370
artikel
15 Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C SIMIN, M.
2007
10 p. 1153-1162
artikel
16 Colonic stent versus surgery for the management of acute malignant colonic obstruction: a decision analysis SIDDIQUI, A.
2007
10 p. 1379-1386
artikel
17 Corpus-predominant gastritis as a risk factor for false-negative 13C-urea breath test results CAPURSO, G.
2006
10 p. 1453-1460
artikel
18 Corrigendum 2006
10 p. 1506
artikel
19 Corrigendum 2007
10 p. 1251-1252
artikel
20 Costs and thresholds in cost-effectiveness analysis S artore, M. E.
2007
10 p. 1455-1456
artikel
21 Cost–utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C LIN, W.-A.
2006
10 p. 1483-1493
artikel
22 Early versus late surgery for ileo-caecal Crohn’s disease ARATARI, A.
2007
10 p. 1303-1312
artikel
23 Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study KIENZLE-HORN, S.
2006
10 p. 1479-1488
artikel
24 Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis WINSTEAD, N. S.
2007
10 p. 1371-1377
artikel
25 Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians JUYAL, G.
2007
10 p. 1325-1332
artikel
26 Excellent therapy for Helicobacter pylori infection B ateson, M. C.
2006
10 p. 1505
artikel
27 Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study RAHME, E.
2007
10 p. 1387-1398
artikel
28 Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease D'INCÀ, R.
2006
10 p. 1455-1461
artikel
29 Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practice LANGERS, P.
2007
10 p. 1447-1454
artikel
30 Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial LIONETTI, E.
2006
10 p. 1461-1468
artikel
31 Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study ZEZOS, P.
2006
10 p. 1443-1453
artikel
32 Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients FABRIZI, F.
2006
10 p. 1413-1422
artikel
33 Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial ROSSIGNOL, J.-F.
2006
10 p. 1423-1430
artikel
34 Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study HOLM, K.
2006
10 p. 1463-1472
artikel
35 Oral budesonide in the treatment of chronic refractory pouchitis GIONCHETTI, P.
2007
10 p. 1231-1236
artikel
36 Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors THOMSEN, R. W.
2006
10 p. 1431-1438
artikel
37 Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C RAISON, C. L.
2007
10 p. 1163-1174
artikel
38 Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma BALDAN, A.
2006
10 p. 1495-1501
artikel
39 Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease KAUKINEN, K.
2007
10 p. 1237-1245
artikel
40 Publication of a negative trial without disclosing the drug D e P onti, F.
2007
10 p. 1247-1249
artikel
41 Publication of a negative trial without disclosing the drug: author's reply A ziz, Q.
2007
10 p. 1248-1249
artikel
42 Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease FORNARI, F.
2007
10 p. 1345-1354
artikel
43 Resource use in patients with Crohn’s disease treated with infliximab SARO, C.
2007
10 p. 1313-1323
artikel
44 Review article: drug hepatotoxicity CHANG, C. Y.
2007
10 p. 1135-1151
artikel
45 Review article: interactions between genotype and response to therapy in inflammatory bowel diseases HERRLINGER, K. R.
2006
10 p. 1403-1412
artikel
46 Review article: oesophageal spasm – diagnosis and management TUTUIAN, R.
2006
10 p. 1393-1402
artikel
47 Review article: the assessment of liver function using breath tests ILAN, Y.
2007
10 p. 1293-1302
artikel
48 Review article: uncomplicated diverticular disease of the colon PETRUZZIELLO, L.
2006
10 p. 1379-1391
artikel
49 Review article: vaccination and viral hepatitis – current status and future prospects KOFF, R. S.
2007
10 p. 1285-1292
artikel
50 Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study MUNK, E. M.
2007
10 p. 1203-1210
artikel
51 Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial MINER, P. B.
2006
10 p. 1403-1413
artikel
52 Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy GOLDSTEIN, J. L.
2007
10 p. 1211-1222
artikel
53 Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease GUNARATNAM, N. T.
2006
10 p. 1473-1477
artikel
54 Temporal trends in new and recurrent oesophageal strictures in a Medicare population EL-SERAG, H. B.
2007
10 p. 1223-1229
artikel
55 The epidemiology and virology of hepatitis C virus genotype 5 in central France ABERGEL, A.
2007
10 p. 1437-1446
artikel
56 The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C LO IACONO, O.
2007
10 p. 1181-1191
artikel
57 The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor GOLDSTEIN, J. L.
2006
10 p. 1489-1498
artikel
58 The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery JETHWA, P.
2007
10 p. 1175-1180
artikel
59 The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy LÓPEZ-ALCOROCHO, J. M.
2007
10 p. 1193-1201
artikel
60 The role of hepatitis E virus testing in drug-induced liver injury DALTON, H. R.
2007
10 p. 1429-1435
artikel
61 Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures GISBERT, J. P.
2006
10 p. 1469-1474
artikel
                             61 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland